A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
O n a Friday in April, I hopped into an Uber to a fish market in San Francisco with a couple of tech founders on a mission to buy lobsters. Not for dinner, but for science: The du ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results